First Commonwealth Financial Corp Abbott Laboratories Transaction History

First Commonwealth Financial Corp

$374 Million
Q2 2024

A detailed history of First Commonwealth Financial Corp transactions in Abbott Laboratories stock. As of the latest transaction made, First Commonwealth Financial Corp holds 6,808 shares of ABT stock, worth $773,661. This represents 0.19% of its overall portfolio holdings.

Number of Shares

6,808

Previous 6,052 12.49%

Holding current value

$773,661

Previous $687,000 2.91%

% of portfolio

0.19%

Previous 0.19%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $76,151 - $85,004	756 Added 12.49%	6,808 $707,000
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $36,470 - $40,279	333 Added 5.82%	6,052 $687,000
Q2 2023 Aug 10, 2023	SELL	$100.78 - $112.29 $29,528 - $32,900	-293 Reduced 4.87%	5,719 $623,000
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $90,564 - $106,599	-935 Reduced 13.46%	6,012 $608,000
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $9,410 - $11,040	-99 Reduced 1.41%	6,947 $762,000
Q3 2022 Nov 09, 2022	BUY	$96.76 - $112.03 $9,579 - $11,090	99 Added 1.43%	7,046 $681,000
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $44,400 - $53,665	-435 Reduced 5.89%	6,947 $755,000
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $21,891 - $26,695	-192 Reduced 2.53%	7,382 $874,000
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $693 - $848	-6 Reduced 0.08%	7,574 $1.07 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $6,766 - $7,485	-58 Reduced 0.76%	7,580 $896,000
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $32,477 - $38,230	307 Added 4.19%	7,638 $885,000
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $77,276 - $91,043	-710 Reduced 8.83%	7,331 $879,000
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $3,675 - $4,004	35 Added 0.44%	8,041 $881,000
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $36,472 - $44,293	398 Added 5.23%	8,006 $872,000
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $19,142 - $24,500	250 Added 3.4%	7,608 $695,000
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $57,982 - $84,786	923 Added 14.34%	7,358 $581,000
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $4,583 - $4,969	56 Added 0.88%	6,435 $539,000
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $23,321 - $27,200	320 Added 5.28%	6,379 $537,000
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $18,938 - $22,897	-286 Reduced 4.51%	6,059 $484,000
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $6,621 - $7,501	-101 Reduced 1.57%	6,345 $458,000
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $15,993 - $19,293	-263 Reduced 3.92%	6,446 $473,000
Q2 2018 Aug 13, 2018	SELL	$57.57 - $63.54 $31,433 - $34,692	-546 Reduced 7.53%	6,709 $409,000
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $89,806 - $101,537	-1,596 Reduced 18.03%	7,255 $435,000
Q4 2017 Feb 15, 2018	SELL	$53.68 - $57.47 $122,014 - $130,629	-2,273 Reduced 20.43%	8,851 $505,000
Q3 2017 Nov 13, 2017	SELL	$48.06 - $53.64 $141,392 - $157,808	-2,942 Reduced 20.92%	11,124 $594,000
Q2 2017 Aug 14, 2017	BUY	N/A	14,066	14,066 $684,000

Others Institutions Holding ABT

# of Institutions

3,136

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Commonwealth Financial Corp , based on Form 13F filings with the SEC.

News

Stay updated on First Commonwealth Financial Corp with notifications on news.

Account

First Commonwealth Financial Corp Abbott Laboratories Transaction History